Indies Pharma Jamaica Limited reported earnings results for the fourth quarter and full year ended October 31, 2023. For the fourth quarter, the company reported sales was JMD 268.56 million compared to JMD 209.65 million a year ago. Net income was JMD 34.41 million compared to JMD 32.93 million a year ago. Basic earnings per share from continuing operations was JMD 0.0258 compared to JMD 0.0247 a year ago.
For the full year, sales was JMD 1,055.46 million compared to JMD 937.28 million a year ago. Net income was JMD 210.39 million compared to JMD 222.97 million a year ago. Basic earnings per share from continuing operations was JMD 0.1578 compared to JMD 0.1656 a year ago.